2020 Food Allergy Gordon Research Conference and Gordon Research Seminar

食物过敏研究正在迅速发展，并日益多学科，因为全球意识 这种复杂的、多因素的、危及生命的疾病的发病率会加快。有史以来第一次第三阶段试验 和其他过敏性疾病一样，生物制剂已经完成了 未来几年重塑临床治疗方法的潜力。 然而，关于饮食抗原免疫机制的非常基本的问题 健康和疾病仍然没有答案，在某些情况下才刚刚开始 系统地解决了。更好地理解机制，如如何与生俱来和适应 免疫细胞与神经感觉通路相互作用，感知饮食并调节消化和 免疫系统将很可能导致新的更合理和更有效的预防策略 和治疗。更好地了解Th2免疫在神经发育和 肿瘤学可能为安全应用迅速出现的和潜在的 针对食物过敏、特应性皮炎、哮喘等问题的变革性生物制剂 以及其他过敏性疾病。2020年食物过敏戈登大会的总体目标是 提升食物过敏研究的质与量。我们致力于吸引顶尖人才 该领域的研究人员，并充分整合实习生、早期职业调查人员，特别是 妇女和少数民族研究人员，以更好地反映并最终增加真正的多样性 这一新兴领域的影响很大，而且越来越大。

Food allergy research is rapidly evolving and increasingly multidisciplinary, as global awareness of this complex, multifactorial, life-threatening disease accelerates. The first ever phase III trials of therapeutics have recently been completed, and like other allergic disease, biologics have the potential to reshape treatment approaches in the clinic over the coming next few years. However, very fundamental questions about the mechanisms of immunity to dietary antigens in health and disease remain unanswered and in some cases are just beginning to be systematically addressed. Better understanding mechanisms such as how innate and adaptive immune cells interact with neurosensory pathways to sense diet and regulate the digestive and immune systems will very likely lead to new more rational and effective prevention strategies and treatments. Better understanding the role of Th2 immunity in neurodevelopment and oncology may provide important insights for safe application of rapidly emerging and potentially transformational biologics to the problems of food allergy as well as atopic dermatitis, asthma and other allergic diseases. The overall aim for the 2020 Food Allergy Gordon Conference is to enhance the quality and quantity of food allergy research. We are committed to attracting top researchers in the field, and fully integrating trainees, early career investigators, and especially women and minority researchers, to better reflect and ultimately increase the true diversity of this emerging field of high and increasing impact.